Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Q32 Bio (QTTB) Depreciation and Depletion (2017 - 2025)

Q32 Bio (QTTB) has 9 years of Depreciation and Depletion data on record, last reported at $90000.0 in Q4 2025.

  • For Q4 2025, Depreciation and Depletion fell 32.33% year-over-year to $90000.0; the TTM value through Dec 2025 reached $391000.0, down 21.8%, while the annual FY2025 figure was $391000.0, 21.8% down from the prior year.
  • Depreciation and Depletion reached $90000.0 in Q4 2025 per QTTB's latest filing, down from $101000.0 in the prior quarter.
  • Across five years, Depreciation and Depletion topped out at $2.1 million in Q4 2021 and bottomed at $90000.0 in Q4 2025.
  • Average Depreciation and Depletion over 5 years is $554200.0, with a median of $126000.0 recorded in 2023.
  • Peak YoY movement for Depreciation and Depletion: rose 9.07% in 2021, then tumbled 86.04% in 2022.
  • A 5-year view of Depreciation and Depletion shows it stood at $2.1 million in 2021, then crashed by 86.04% to $296000.0 in 2022, then plummeted by 57.77% to $125000.0 in 2023, then grew by 6.4% to $133000.0 in 2024, then plummeted by 32.33% to $90000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Depreciation and Depletion were $90000.0 in Q4 2025, $101000.0 in Q3 2025, and $100000.0 in Q2 2025.